Cargando…
Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders
Carbonic anhydrases (CAs, EC 4.2.1.1) are enzymes involved in a multitude of diseases, and their inhibitors are in clinical use as drugs for the management of glaucoma, epilepsy, obesity, and tumours. In the last decade, multitargeting approaches have been proposed by hybridisation of CA inhibitors...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330743/ https://www.ncbi.nlm.nih.gov/pubmed/34325588 http://dx.doi.org/10.1080/14756366.2021.1945049 |